• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

FDA works with Pfizer on injectable opioids for veterinary use

January 4, 2019
dvm360, dvm360 February 2019, Volume 50, Issue 2

Agency collaborates with human pharma company to keep hydromorphone, morphine available for surgical and trauma pain in animals during supply shortage.

In mid-December, the FDA announced that it was working with Pfizer Inc. to help alleviate a shortage of certain injectable opioids for treating pain in animals by facilitating the availability of a limited amount of product labeled for human use. Most of the opioid pain medications used in veterinary medicine are approved for use in humans but also used in animals in an extralabel capacity, the agency says in a media release.

“FDA is aware that the opioid shortage has been acutely felt in the veterinary community, just as it has in hospitals and healthcare settings providing critical care and pain management in human medicine,” the agency says in a letter to veterinarians released in December.

In September, the FDA's Center for Veterinary Medicine (CVM) became aware that veterinarians who relied on these products for pain control in their patients were no longer able to obtain them through their standard distribution channels, according to the release. This was due to a recent shortage of injectable opioids and to Pfizer's decision to restrict distribution of such products for human use during the ongoing shortage.

The CVM met with Pfizer about the veterinary community's need for injectable opioids and discussed how a limited supply imported from other countries could be made available for use in the U.S. veterinary market, the release states. The FDA had already given Pfizer permission to import injectable hydromorphone to help alleviate the shortage in human medicine. As a result, this product is now available in limited quantities for pain management in animals, the release indicates.

Advertisement

In addition to hydromorphone, Pfizer has also made injectable morphine available to veterinarians in the U.S., according to the release. The CVM says these products are in short supply but will continue to be available to veterinary practitioners when supply increases.

Veterinarians can purchase the products through their normal distribution chains, which have been alerted that they are now available in limited supply for the veterinary market, according to the CVM. Pfizer reports that it expects the opioid shortage to end early this year and that it will continue to keep these products available to the veterinary market in the interim.

download issueDownload Issue: dvm360 February 2019

Related Content:

Pain ManagementAnesthesiaMedicalSurgeryBreaking Newsdvm360 February 2019
An update on copper concerns in pet foods
An update on copper concerns in pet foods
Educating clients on brachycephalic breeds
Educating clients on brachycephalic breeds
Traditional and holistic treatments for giardia
Traditional and holistic treatments for giardia

Advertisement

Latest News

An update on copper concerns in pet foods

Dental hacks to make every case more manageable

Q&A with a keynote: Walter Brown, RVTg, VTS, ECC

News wrap-up: This week’s headlines, plus dvm360® launches its first CE podcast

View More Latest News
Advertisement